Galmed Pharmaceuticals (GLMD) Q2 2026 Earnings

1AprConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-0.89
-0.7
-0.52
-0.33

Details

Expected EPS
-0.51
Actual EPS
N/A
Surprise EPS
0.51
Surprise Percent
+100%

Description

Galmed Pharmaceuticals (GLMD) will report earnings of for Q2 2026 on April 01, 2026.

0 Comments

Share your thoughts